Dresden Glaucoma and Treatment Study Evaluating Follow-up and Therapy Quality in a University Hospital
Led by Technische Universität Dresden · Updated on 2026-09-16
10000
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the quality of follow-up and treatment for patients with glaucoma by collecting and analyzing anonymized data from a tertiary university hospital glaucoma service. It includes patients with various types of glaucoma and related conditions such as ocular hypertension and glaucoma suspects. The study focuses on ensuring effective patient care through continuous data assessment over many years.
Participants medical data such as age, sex, refraction, family history, glaucoma duration, and treatment history are collected. Clinical parameters from various eye tests including 24-hour Goldmann-applanation tonometry, biomicroscopy, gonioscopy, Heidelberg Retinal Tomograph, Scanning-Laser-Polarimetry, optical coherence tomography, Pentacam, Ocular Response Analyzer, Corvis ST, and perimetry are recorded and analyzed. This comprehensive data collection supports detailed monitoring of glaucoma progression and treatment effects.
Throughout the study, patients are continuously monitored and their data anonymized for analysis to assess follow-up intervals, treatment quality, and the effectiveness and safety of glaucoma laser therapy and surgery. The study spans up to 20 years, allowing long-term evaluation of patient outcomes. Researchers track treatment-related adverse events and intraocular pressure changes to better understand care quality over time.
CONDITIONS
Brief Title
Dresden Glaucoma and Treatment Study (DGTS)
Research Team
K
Karin R Pillunat, MD
L
Lutz E Pillunat, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Manifest glaucoma, ocular hypertension, or glaucoma suspect
Participants aged 18 years or older
All genders are eligible
You will not qualify if you...
Under 18 years of age
Presence of corneal diseases
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Monitoring
Duration - Up to 20 years
Participants' clinical data and routine eye exam results are collected and anonymized for analysis to evaluate follow-up and treatment quality.
Regular clinical visits as part of usual care
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Community-Based Eye Screening Using Artificial Intelligence to Prevent Blindness in Coastal Bangladesh
Study of Direct Selective Laser Trabeculoplasty DSLT to Reduce Eye Pressure by Over 20% Without Medication
in Adults with Untreated Primary Open-Angle Glaucoma or Ocular Hypertension
Evaluation of ASP2767 Gene Therapy Safety and Vision Effects in Open-Angle Glaucoma Patients Using Randomized, Controlled Injections
Evaluating MINIject S Implant Safety and Usability in Open Angle Glaucoma Patients Using Different Insertion Tools
An International Multi-center Cohort Study with Combined Glaucoma and Cataract Surgery Assessment
Study of Oral Semaglutide for Treating Open-Angle Glaucoma
Evaluating Safety and Retinal Function Improvement Over 6 Months
Comparing Hydrus Microstent and Goniotomy Procedures Combined With Cataract Surgery for Mild to Moderate Open-Angle Glaucoma
Comparing Rhopressa and Timolol Eye Drops Using Adaptive Optics OCT
for Retinal Nerve Cell Protection in Adults with Open-Angle Glaucoma
Pilot Study Testing a New Auto-aligned Handheld OCT Device for Imaging the Retina in Adults and Children
Long-term Follow-up of Hydrus Implant With Phacoemulsification for Lowering Eye Pressure in Glaucoma Patients
Study of Light Sensitivity Effects on Sleep, Mood, Alertness, and Thinking in Adults with Glaucoma Compared to Healthy Adults Aged 45 to 75